{"id":128467,"date":"2025-06-04T09:45:54","date_gmt":"2025-06-04T08:45:54","guid":{"rendered":"https:\/\/easo.org\/?p=128467"},"modified":"2025-06-04T09:45:54","modified_gmt":"2025-06-04T08:45:54","slug":"easo-ecn-interview-with-dr-julia-beck","status":"publish","type":"post","link":"https:\/\/easo.org\/fr\/easo-ecn-interview-with-dr-julia-beck\/","title":{"rendered":"Entretien de l'EASO ECN avec le Dr Julia Beck"},"content":{"rendered":"

YEUX (https:\/\/www.ese-hormones.org\/what-we-do\/our-communities\/for-early-career-ese-young-endocrinologists-and-scientists-eyes\/<\/a>) (ESE Young Endocrinologists and Scientists) est la communaut\u00e9 des jeunes professionnels de la Soci\u00e9t\u00e9 europ\u00e9enne d'endocrinologie (ESE) et repr\u00e9sente environ un tiers de l'ensemble des membres de l'ESE. Son comit\u00e9 repr\u00e9sente l'ensemble de la communaut\u00e9 des jeunes professionnels et participe \u00e0 tous les comit\u00e9s, projets et activit\u00e9s cl\u00e9s de l'ESE. Son objectif est d'apporter une perspective diff\u00e9rente, en mettant l'accent sur les connaissances endocrinologiques de demain et en soulignant les aspects essentiels de l'implication clinique et de la recherche pour les jeunes chercheurs d'aujourd'hui, tout en cr\u00e9ant un r\u00e9seau solide et en facilitant la croissance professionnelle des jeunes professionnels.<\/p>\n

Bienvenue, Dr Julia Beck ! Veuillez vous pr\u00e9senter.<\/strong><\/p>\n

\"A<\/p>\n

Merci de m'offrir cette formidable occasion de partager mon travail avec la communaut\u00e9 EASO. Outre mon r\u00f4le de repr\u00e9sentante des jeunes chercheurs (EYES) au sein de la Soci\u00e9t\u00e9 europ\u00e9enne d'endocrinologie, je suis clinicienne-chercheuse en endocrinologie, diab\u00e8te et m\u00e9tabolisme \u00e0 l'h\u00f4pital universitaire de B\u00e2le, en Suisse. Parall\u00e8lement \u00e0 ma formation clinique en endocrinologie, je participe \u00e0 plusieurs projets de recherche clinique dans le cadre de mon doctorat en m\u00e9decine. Mon groupe de recherche (https:\/\/x.com\/ClinNeuroEndo<\/a>, https:\/\/web-cdn.bsky.app\/profile\/neuroendo-basel.bsky.social<\/a>), dirig\u00e9 par le professeur Mirjam Christ-Crain, s'int\u00e9resse particuli\u00e8rement \u00e0 la neuroendocrinologie, notamment au d\u00e9ficit en AVP et \u00e0 l'hyponatr\u00e9mie, avec des int\u00e9r\u00eats de recherche qui recoupent d'autres domaines de l'endocrinologie.<\/p>\n

Pouvez-vous nous parler de vos int\u00e9r\u00eats cliniques et de votre exp\u00e9rience en mati\u00e8re de recherche sur l'ob\u00e9sit\u00e9 ?<\/strong><\/p>\n

Travail clinique sur l'ob\u00e9sit\u00e9<\/h3>\n

L'ob\u00e9sit\u00e9 est devenue l'un des domaines les plus dynamiques et les plus importants de notre pratique clinique en endocrinologie, avec des cons\u00e9quences socio-\u00e9conomiques significatives. Par cons\u00e9quent, la prise en charge de l'ob\u00e9sit\u00e9 fait \u00e9galement partie int\u00e9grante de mon travail clinique. En Suisse, nous avons la chance d'\u00eatre l'un des rares pays europ\u00e9ens o\u00f9 les analogues du GLP-1 sont pris en charge par les assurances m\u00e9dicales pour le traitement de l'ob\u00e9sit\u00e9, ce qui nous permet d'offrir \u00e0 un large \u00e9ventail de patients une option th\u00e9rapeutique efficace dans le cadre d'un programme structur\u00e9 de lutte contre l'ob\u00e9sit\u00e9 et d'une approche multidisciplinaire. Notre centre universitaire de lutte contre l'ob\u00e9sit\u00e9 \u00e0 B\u00e2le, dirig\u00e9 par le professeur Katharina Timper, comprend non seulement des sp\u00e9cialistes en endocrinologie, mais aussi une \u00e9quipe multidisciplinaire compos\u00e9e de nutritionnistes, de psychologues et de chirurgiens visc\u00e9raux. \u00c0 mon avis, ce travail multidisciplinaire est un facteur crucial pour offrir des soins de haut niveau aux patients souffrant d'ob\u00e9sit\u00e9, ce que j'appr\u00e9cie et valorise beaucoup.<\/p>\n

Recherche sur l'ob\u00e9sit\u00e9<\/h3>\n

Gr\u00e2ce \u00e0 notre \u00e9troite collaboration entre les domaines clinique et de la recherche \u00e0 B\u00e2le, nous b\u00e9n\u00e9ficions d'un excellent environnement de recherche dans notre centre, qui cr\u00e9e une synergie pr\u00e9cieuse entre les soins aux patients et les questions de recherche scientifique. La collaboration avec notre service d'hypertension et une clinique sp\u00e9cialis\u00e9e dans le sevrage tabagique en est un exemple. Les analogues du GLP-1 continuant \u00e0 se g\u00e9n\u00e9raliser, non seulement pour le traitement de l'ob\u00e9sit\u00e9, mais aussi comme option potentielle pour les troubles addictifs, nous avons men\u00e9 un essai prospectif, randomis\u00e9, en double aveugle et contr\u00f4l\u00e9 par placebo afin d'\u00e9tudier le r\u00f4le d'un traitement de 12 semaines par dulaglutide dans le sevrage tabagique. Dans une analyse secondaire pr\u00e9d\u00e9finie, nous avons r\u00e9cemment examin\u00e9 les effets du dulaglutide sur les variations de la pression art\u00e9rielle pendant le sevrage tabagique. Les r\u00e9sultats ont r\u00e9cemment \u00e9t\u00e9 publi\u00e9s dans le Journal europ\u00e9en de cardiologie pr\u00e9ventive <\/em>(Beck et al., Eur. J. Prev. Cardiol. (2025) https:\/\/doi.org\/10.1093\/eurjpc\/zwaf055<\/a>). Il est important de noter que, bien que le dulaglutide ait initialement contribu\u00e9 \u00e0 la perte de poids et \u00e0 la r\u00e9duction de la pression art\u00e9rielle, nous avons observ\u00e9 un effet rebond, avec une augmentation du poids et de la pression art\u00e9rielle apr\u00e8s un an. Nos donn\u00e9es soulignent que les effets rebond sont un facteur crucial \u00e0 prendre en compte lors de la mise en \u0153uvre d'analogues du GLP-1 dans les troubles addictifs afin de garantir le succ\u00e8s du traitement \u00e0 long terme.<\/p>\n

Activit\u00e9s dans le domaine de l'ob\u00e9sit\u00e9 dans le cadre du comit\u00e9 ESE EYES<\/strong><\/p>\n

L'ob\u00e9sit\u00e9 est un sujet qui rev\u00eat une importance croissante au sein de la Soci\u00e9t\u00e9 europ\u00e9enne d'endocrinologie (ESE). Dans le cadre de mes fonctions au sein du comit\u00e9 EYES, je participe \u00e0 plusieurs initiatives importantes visant \u00e0 faire progresser la recherche sur l'ob\u00e9sit\u00e9 et l'\u00e9laboration de politiques.<\/p>\n

L'ob\u00e9sit\u00e9 dans la feuille de route ESE EndoCompass \u2013<\/h3>\n

L'ob\u00e9sit\u00e9 joue un r\u00f4le cl\u00e9 dans la feuille de route ESE EndoCompass (https:\/\/www.ese-hormones.org\/what-we-do\/research\/the-endocompass-project\/<\/a>), une initiative strat\u00e9gique visant \u00e0 d\u00e9finir les priorit\u00e9s de recherche dans le domaine de la sant\u00e9 et des maladies endocriniennes, \u00e0 \u00e9valuer l'\u00e9tat actuel des connaissances et \u00e0 identifier les priorit\u00e9s de recherche futures. Cette feuille de route a pour objectif d'orienter les futurs appels \u00e0 projets de recherche et les programmes de financement. Je suis honor\u00e9 d'avoir contribu\u00e9 \u00e0 la section consacr\u00e9e \u00e0 la communication entre le cerveau et la p\u00e9riph\u00e9rie et aux facteurs environnementaux dans l'ob\u00e9sit\u00e9. La feuille de route EndoCompass sera bient\u00f4t publi\u00e9e dans l'European Journal of Endocrinology.<\/p>\n

Groupe de travail sur l'ob\u00e9sit\u00e9<\/h3>\n

Gr\u00e2ce aux progr\u00e8s rapides r\u00e9alis\u00e9s dans la compr\u00e9hension de la physiopathologie et du traitement de l'ob\u00e9sit\u00e9, la prise en charge de cette maladie a \u00e9t\u00e9 r\u00e9volutionn\u00e9e. En tant que membres du groupe de travail sur l'ob\u00e9sit\u00e9 de l'ESE, nous nous engageons \u00e0 approfondir nos recherches dans ce domaine crucial de l'endocrinologie, dans le but non seulement d'am\u00e9liorer les options th\u00e9rapeutiques, mais aussi de faire progresser les strat\u00e9gies pr\u00e9ventives et l'\u00e9laboration de politiques en mati\u00e8re d'ob\u00e9sit\u00e9.<\/p>\n

Lancement de notre nouveau Ob\u00e9sit\u00e9 et endocrinologie<\/em> Journal<\/h3>\n

Nous sommes ravis d'annoncer le lancement de Ob\u00e9sit\u00e9 et endocrinologie<\/em><\/strong> (https:\/\/academic.oup.com\/obendo<\/a>), notre nouvelle revue consacr\u00e9e \u00e0 l'avancement de la recherche sur l'ob\u00e9sit\u00e9, dont le premier num\u00e9ro sera publi\u00e9 en mai 2025. La revue offrira une plateforme compl\u00e8te couvrant la recherche fondamentale, translationnelle et clinique, ainsi que les avanc\u00e9es en mati\u00e8re de diagnostic, de traitement et de troubles m\u00e9taboliques. Nous vous encourageons \u00e0 partager la nouvelle du lancement de la revue avec vos coll\u00e8gues et vous invitons, en tant qu'experts dans le domaine de la recherche sur l'ob\u00e9sit\u00e9, \u00e0 soumettre vos travaux afin de contribuer \u00e0 l'avancement et \u00e0 l'avenir de la recherche sur l'ob\u00e9sit\u00e9.<\/p>\n

Comment envisagez-vous la collaboration entre ESE EYES et le r\u00e9seau EASO Early Career Network ?<\/strong><\/em><\/p>\n

Je suis convaincu que l'EASO et l'ESE ont divers int\u00e9r\u00eats et passions communs. En tant que professionnels en d\u00e9but de carri\u00e8re, nous avons une occasion unique de nous inspirer mutuellement, d'\u00e9changer nos connaissances et de grandir ensemble, que ce soit par la recherche, le d\u00e9veloppement professionnel ou le soutien communautaire. Vous pouvez vous tenir au courant de nos activit\u00e9s EYES sur\u00a0Twitter\/X<\/a>, Bluesky (https:\/\/web-cdn.bsky.app\/profile\/ese-eyes.bsky.social<\/a>),LinkedIn<\/a>,\u00a0Instagram<\/a>\u00a0et\u00a0Facebook<\/a>, ou si vous avez des commentaires ou des questions, n'h\u00e9sitez pas \u00e0 me contacter directement (https:\/\/www.linkedin.com\/in\/julia-beck-md\/<\/a>, https:\/\/bsky.app\/profile\/juliabeck01.bsky.social<\/a> ).<\/p>","protected":false},"excerpt":{"rendered":"

EYES (https:\/\/www.ese-hormones.org\/what-we-do\/our-communities\/for-early-career-ese-young-endocrinologists-and-scientists-eyes\/) (ESE Young Endocrinologists and Scientists) is the early career community of the European Society of Endocrinology (ESE) and represents around 1\/3 of the whole ESE membership. Its committee represents the entire Early Career community and participates in all key ESE Committees, projects and activities. Its purpose is to bring a different perspective, focusing […]<\/p>\n","protected":false},"author":1,"featured_media":128468,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[538],"tags":[],"class_list":["post-128467","post","type-post","status-publish","has-post-thumbnail","hentry","category-ecn-spotlight"],"yoast_head":"\nEASO ECN interview with Dr Julia Beck - EASO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/easo.org\/fr\/easo-ecn-interview-with-dr-julia-beck\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EASO ECN interview with Dr Julia Beck - EASO\" \/>\n<meta property=\"og:description\" content=\"EYES (https:\/\/www.ese-hormones.org\/what-we-do\/our-communities\/for-early-career-ese-young-endocrinologists-and-scientists-eyes\/) (ESE Young Endocrinologists and Scientists) is the early career community of the European Society of Endocrinology (ESE) and represents around 1\/3 of the whole ESE membership. Its committee represents the entire Early Career community and participates in all key ESE Committees, projects and activities. Its purpose is to bring a different perspective, focusing […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/easo.org\/fr\/easo-ecn-interview-with-dr-julia-beck\/\" \/>\n<meta property=\"og:site_name\" content=\"EASO\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-04T08:45:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/easo.org\/wp-content\/uploads\/2025\/06\/eyes-group.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"EASO Secretariat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"EASO Secretariat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/\"},\"author\":{\"name\":\"EASO Secretariat\",\"@id\":\"https:\\\/\\\/easo.org\\\/#\\\/schema\\\/person\\\/df04141f0799503a007288b3899de859\"},\"headline\":\"EASO ECN interview with Dr Julia Beck\",\"datePublished\":\"2025-06-04T08:45:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/\"},\"wordCount\":944,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/eyes-group.jpeg\",\"articleSection\":[\"ECN Spotlight\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/\",\"url\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/\",\"name\":\"EASO ECN interview with Dr Julia Beck - EASO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/easo.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/eyes-group.jpeg\",\"datePublished\":\"2025-06-04T08:45:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/easo.org\\\/#\\\/schema\\\/person\\\/df04141f0799503a007288b3899de859\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#primaryimage\",\"url\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/eyes-group.jpeg\",\"contentUrl\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/eyes-group.jpeg\",\"width\":700,\"height\":400,\"caption\":\"Seven people stand indoors, smiling for a group photo near large windows, wearing business casual attire and conference name badges.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/easo.org\\\/easo-ecn-interview-with-dr-julia-beck\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/easo.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EASO ECN interview with Dr Julia Beck\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/easo.org\\\/#website\",\"url\":\"https:\\\/\\\/easo.org\\\/\",\"name\":\"EASO\",\"description\":\"The European Association for the Study of Obesity\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/easo.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/easo.org\\\/#\\\/schema\\\/person\\\/df04141f0799503a007288b3899de859\",\"name\":\"EASO Secretariat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g\",\"caption\":\"EASO Secretariat\"},\"url\":\"https:\\\/\\\/easo.org\\\/fr\\\/author\\\/chris\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EASO ECN interview with Dr Julia Beck - EASO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/easo.org\/fr\/easo-ecn-interview-with-dr-julia-beck\/","og_locale":"fr_FR","og_type":"article","og_title":"EASO ECN interview with Dr Julia Beck - EASO","og_description":"EYES (https:\/\/www.ese-hormones.org\/what-we-do\/our-communities\/for-early-career-ese-young-endocrinologists-and-scientists-eyes\/) (ESE Young Endocrinologists and Scientists) is the early career community of the European Society of Endocrinology (ESE) and represents around 1\/3 of the whole ESE membership. Its committee represents the entire Early Career community and participates in all key ESE Committees, projects and activities. Its purpose is to bring a different perspective, focusing […]","og_url":"https:\/\/easo.org\/fr\/easo-ecn-interview-with-dr-julia-beck\/","og_site_name":"EASO","article_published_time":"2025-06-04T08:45:54+00:00","og_image":[{"width":700,"height":400,"url":"https:\/\/easo.org\/wp-content\/uploads\/2025\/06\/eyes-group.jpeg","type":"image\/jpeg"}],"author":"EASO Secretariat","twitter_card":"summary_large_image","twitter_misc":{"Written by":"EASO Secretariat","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#article","isPartOf":{"@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/"},"author":{"name":"EASO Secretariat","@id":"https:\/\/easo.org\/#\/schema\/person\/df04141f0799503a007288b3899de859"},"headline":"EASO ECN interview with Dr Julia Beck","datePublished":"2025-06-04T08:45:54+00:00","mainEntityOfPage":{"@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/"},"wordCount":944,"commentCount":0,"image":{"@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#primaryimage"},"thumbnailUrl":"https:\/\/easo.org\/wp-content\/uploads\/2025\/06\/eyes-group.jpeg","articleSection":["ECN Spotlight"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/","url":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/","name":"EASO ECN interview with Dr Julia Beck - EASO","isPartOf":{"@id":"https:\/\/easo.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#primaryimage"},"image":{"@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#primaryimage"},"thumbnailUrl":"https:\/\/easo.org\/wp-content\/uploads\/2025\/06\/eyes-group.jpeg","datePublished":"2025-06-04T08:45:54+00:00","author":{"@id":"https:\/\/easo.org\/#\/schema\/person\/df04141f0799503a007288b3899de859"},"breadcrumb":{"@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#primaryimage","url":"https:\/\/easo.org\/wp-content\/uploads\/2025\/06\/eyes-group.jpeg","contentUrl":"https:\/\/easo.org\/wp-content\/uploads\/2025\/06\/eyes-group.jpeg","width":700,"height":400,"caption":"Seven people stand indoors, smiling for a group photo near large windows, wearing business casual attire and conference name badges."},{"@type":"BreadcrumbList","@id":"https:\/\/easo.org\/easo-ecn-interview-with-dr-julia-beck\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/easo.org\/"},{"@type":"ListItem","position":2,"name":"EASO ECN interview with Dr Julia Beck"}]},{"@type":"WebSite","@id":"https:\/\/easo.org\/#website","url":"https:\/\/easo.org\/","name":"EASO","description":"Association europ\u00e9enne pour l'\u00e9tude de l'ob\u00e9sit\u00e9","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/easo.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/easo.org\/#\/schema\/person\/df04141f0799503a007288b3899de859","name":"Secr\u00e9tariat de l'EASO","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g","caption":"EASO Secretariat"},"url":"https:\/\/easo.org\/fr\/author\/chris\/"}]}},"_links":{"self":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts\/128467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/comments?post=128467"}],"version-history":[{"count":1,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts\/128467\/revisions"}],"predecessor-version":[{"id":128470,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts\/128467\/revisions\/128470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/media\/128468"}],"wp:attachment":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/media?parent=128467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/categories?post=128467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/tags?post=128467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}